{
  "columnHierarchy": {
    "epochs": [
      {
        "id": "epoch_1",
        "name": "Screening Phase",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "1811c781-8bed-4bdc-9550-289495f852ba",
          "code": "C98779",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Screening Epoch",
          "instanceType": "Code"
        }
      },
      {
        "id": "epoch_2",
        "name": "Treatment Phase (BR Treatment Period Cycles 1 to 6)",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "1c1593cf-08e7-4092-9c9e-ae12654b3071",
          "code": "C98780",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment Epoch",
          "instanceType": "Code"
        }
      },
      {
        "id": "epoch_3",
        "name": "Treatment Phase (R Treatment Every 2 cycles up to Cycle 30)",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "8be5f665-35b7-4dce-997d-6d8bae3fbd33",
          "code": "C98780",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment Epoch",
          "instanceType": "Code"
        }
      },
      {
        "id": "epoch_4",
        "name": "Treatment Phase (After Cycle 30)",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "b4390bc2-daf2-4316-9b4c-77d7e07ce5a9",
          "code": "C98780",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment Epoch",
          "instanceType": "Code"
        }
      },
      {
        "id": "epoch_5",
        "name": "End of Treatment Visit",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "a3f08895-253b-4973-9be4-54c76527f56f",
          "code": "C98780",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment Epoch",
          "instanceType": "Code"
        }
      },
      {
        "id": "epoch_6",
        "name": "Posttreatment Follow-up Phase",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "8b5cb061-50c3-4a76-bb5c-4b25193caf00",
          "code": "C98780",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment Epoch",
          "instanceType": "Code"
        }
      }
    ],
    "encounters": [
      {
        "id": "enc_1",
        "name": "Screening (Day -30 to randomization)",
        "instanceType": "Encounter",
        "type": {
          "id": "d341221d-c256-4a87-bcfa-03cff111c8f2",
          "code": "C48262",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Screening",
          "instanceType": "Code"
        },
        "epochId": "epoch_1"
      },
      {
        "id": "enc_2",
        "name": "BR Period Day 1",
        "instanceType": "Encounter",
        "type": {
          "id": "6e153067-43ca-4064-9ea2-4ab4eb9569c4",
          "code": "C82517",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Baseline",
          "instanceType": "Code"
        },
        "epochId": "epoch_2"
      },
      {
        "id": "enc_3",
        "name": "BR Period Day 2",
        "instanceType": "Encounter",
        "type": {
          "id": "c939044e-ce73-4b7c-acaa-fbb28c147c8f",
          "code": "C99156",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Scheduled Visit",
          "instanceType": "Code"
        },
        "epochId": "epoch_2"
      },
      {
        "id": "enc_4",
        "name": "R Treatment Day 1",
        "instanceType": "Encounter",
        "type": {
          "id": "4a98dd0a-7754-4e06-8487-72366ac1b453",
          "code": "C82517",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Baseline",
          "instanceType": "Code"
        },
        "epochId": "epoch_3"
      },
      {
        "id": "enc_5",
        "name": "After Cycle 30 Day 1",
        "instanceType": "Encounter",
        "type": {
          "id": "8e71cc34-9261-48c9-b3e0-5445c00a242d",
          "code": "C82517",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Baseline",
          "instanceType": "Code"
        },
        "epochId": "epoch_4"
      },
      {
        "id": "enc_6",
        "name": "End of Treatment (Within 30 days)",
        "instanceType": "Encounter",
        "type": {
          "id": "035f154e-ffca-4c36-8d89-da2dd18afab6",
          "code": "C126070",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "End of Study",
          "instanceType": "Code"
        },
        "epochId": "epoch_5"
      },
      {
        "id": "enc_7",
        "name": "Follow-up until Progressive Disease",
        "instanceType": "Encounter",
        "type": {
          "id": "428c5b14-6c12-49a6-998f-eef32e50a2f6",
          "code": "C99158",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Follow-up",
          "instanceType": "Code"
        },
        "epochId": "epoch_6"
      },
      {
        "id": "enc_8",
        "name": "Survival Follow-up",
        "instanceType": "Encounter",
        "type": {
          "id": "c58b7fec-74cb-4e19-9b2d-4e0791d749bd",
          "code": "C99158",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Follow-up",
          "instanceType": "Code"
        },
        "epochId": "epoch_6"
      }
    ],
    "plannedTimepoints": [
      {
        "id": "pt_1",
        "visit": "Day -30 to randomization",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_1",
        "instanceType": "Timing"
      },
      {
        "id": "pt_2",
        "visit": "Day 1",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_2",
        "instanceType": "Timing"
      },
      {
        "id": "pt_3",
        "visit": "Day 2",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_3",
        "instanceType": "Timing"
      },
      {
        "id": "pt_4",
        "visit": "Day 1",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_4",
        "instanceType": "Timing"
      },
      {
        "id": "pt_5",
        "visit": "Day 1",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_5",
        "instanceType": "Timing"
      },
      {
        "id": "pt_6",
        "visit": "Within 30 days after last dose",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_6",
        "instanceType": "Timing"
      },
      {
        "id": "pt_7",
        "visit": "Until PD",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_7",
        "instanceType": "Timing"
      },
      {
        "id": "pt_8",
        "visit": "Survival",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_8",
        "instanceType": "Timing"
      }
    ]
  },
  "rowGroups": [
    {
      "id": "grp_1",
      "name": "Drug Administration",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "Rituximab 375 mg/m2",
        "Bendamustine hydrochloride 90 mg/m2",
        "Study drug: Arm A: placebo (4 capsules) Arm B: ibrutinib 560 mg (4 capsules)",
        "Dispense study drug and check drug accountability"
      ]
    },
    {
      "id": "grp_2",
      "name": "Ongoing Subject Review",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "Concomitant medications",
        "Adverse events"
      ]
    },
    {
      "id": "grp_3",
      "name": "Procedures",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "Informed consent",
        "Review inclusion/exclusion criteria",
        "Medical and disease history",
        "MCL diagnosis",
        "Vital signs and height",
        "ECOG",
        "Body surface area (BSA)",
        "Weight",
        "Electrocardiogram",
        "Disease-related symptoms and physical examination"
      ]
    },
    {
      "id": "grp_4",
      "name": "Disease Evaluations",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "CT/MRI",
        "PET scan",
        "Endoscopy",
        "Bone marrow aspirate and biopsy",
        "Survival status",
        "Subsequent anti-MCL therapies",
        "PRO questionnaires"
      ]
    },
    {
      "id": "grp_5",
      "name": "Laboratory Assessments",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "Hematology",
        "Serum chemistry",
        "Magnesium",
        "Hepatitis B and C",
        "Urine or serum pregnancy test",
        "Coagulation (aPTT and PT/INR)",
        "Pharmacokinetic sample",
        "Serum immunoglobulin and beta 2-microglobulin",
        "Blood samples for minimal residual disease (MRD)",
        "Blood samples for biomarker evaluations",
        "Fresh lymph node biopsy"
      ]
    }
  ],
  "footnotes": [
    "a. Assessments/procedures should be completed on the day indicated in the Time and Events Schedule",
    "b. Results of tests obtained prior to signing the informed consent conducted as part of the subject's standard care may be used",
    "c. For Day 1, Cycle 1, clinical laboratory tests do not need to be repeated if Screening tests were performed within 5 days",
    "d. During the Treatment Phase, clinical laboratory samples may be obtained on the day of or day prior to dosing",
    "y. Notification of progressive disease and supportive clinical results must be sent within 24 hours",
    "z. Refer to Section 9.1.5 for data collection after the clinical cutoff",
    "aa. Following disease progression, contact will be made to determine survival status every 16 weeks"
  ]
}